Regarding LCNEC, we previously reported a possible association between immunostaining patterns with three neuroendocrine markers (chromogranin A, synaptophysin, and neural‐cell adhesion molecule [NCAM]) and tumor response to chemotherapy. This evidence concerns the gene NCAM1 and large cell neuroendocrine carcinoma.